Evidence for antibiotic use for sore throat and URTI in general practice by Kali, GTJ & Swingler, G
Sore throat and upper respiratory tract
infections (URTIs) are among the com-
monest presenting complaints in general
practice, especially in the paediatric popu-
lation.1,2 Each year children have about
five such infections, and adults two or
three. Most are self-limiting and caused
by viruses, but approximately 15% of sore
throats reflect group A ß-haemolytic
streptococcal (GABS) infections (also
commonly referred to as ‘strep throat’)
and may benefit from antibiotic treat-
ment. Antibiotic use comes at a cost, not
only of the medicine itself, but of side-
effects and of promoting ever-growing
bacterial resistance to antibiotics. Given
the widespread use of antibiotics for these
conditions (60% for adults with the com-
mon cold in the USA3), the costs are con-
siderable.This article attempts to follow a
rational approach to the antibiotic man-
agement of URTIs. We start by consider-
ing a common clinical problem.
CASE 1 
A 2-year-old child presents to a general
practitioner with a 2-day history of fever,
runny nose and cough. He has not been
feeding as well as usual. On examination,
his temperature is 38°C, he has a clear
nasal discharge and a slightly red throat.
The rest of the examination is normal.
What are the questions?
Before starting with an antibiotic we must
ask what we hope to gain for the patient
by doing so. We suggest that in this child
we could aim at reducing the degree and
duration of discomfort, and caregiver's
time off work, and at preventing compli-
cations. Any such benefits would have to
be balanced against the cost and harmful
effects of the treatment.To balance bene-
fits and adverse effects we need to know
not only whether the antibiotic helps
and/or harms, but how much it does of
either.
We might phrase some of the questions as
follows:
• Do antibiotics reduce the severity or
duration of important symptoms in a
2-year-old child with an URTI? If so,
by how much?
• Do antibiotics prevent complications of
URTI?
• Do antibiotics have harmful effects? If
so, how severe and how often?
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There is a common misconception among many
people that antibiotics are necessary for 
common colds and their symptoms. Evidence-
based medicine can provide a rational approach
to this problem.
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Antibiotic use comes at
a cost, not only of the
medicine itself, but of
side-effects and of pro -
moting ever-growing
bacterial resistance to
a n t i b i o t i c s .
Will antibiotics reduce the
severity and duration of his
symptoms?
The best evidence for the effective-
ness of interventions comes from
randomised controlled trials
(RCTs), and good quality system-
atic reviews of RCTs generally
offer the highest level of all. A sys-
tematic review differs from a tradi-
tional review article. It aims to col-
lect and synthesise information
from all applicable research in a
prospective systematic manner.
A recent systematic review of 9
RCTs of antibiotics for the com-
mon cold did not find a significant
impact on general or specific
nasopharyngeal symptoms (odds
ratio (OR) 0.80, 95% confidence
interval (CI) 0.59 - 1.08).4 A sec-
ond systematic review in children
found no change in clinical out-
comes (relative risk (RR) 1.01,
95% CI 0.90 - 1.13).5
However, one RCT found that, in
the 20% of people who had posi-
tive sputum cultures (for
Haemophilus influenzae, Moraxella
catarrhalis, Streptococcus pneumoni-
ae), antibiotics increased the pro-
portion who had recovered by 5
days (27% v. 4% with placebo).6
Therefore, why not culture the
sputum of all patients, and only
treat those who are positive? If
approximately one-quarter of cul-
ture-positive people (27% minus
4%) will benefit, we shall need to
treat approximately 4 people in
order for one of them to benefit.
Considering that only 1 in 5 peo-
ple will be culture-positive, we
would need to culture the sputum
of 20 people to identify 4 people to
treat, so that 1 person will benefit.
If the cost, hassle and side-effects
of 20 sputum cultures and 4 cours-
es of antibiotics are worth 1 addi-
tional person benefiting, then this
approach is worth it. It is up to the
patient and practitioner to decide.
This so-called ‘number needed to
treat’ (NNT) is one tool of an evi-
dence-based approach that helps
provide a more intuitive idea of
how much an intervention will
help in a specific situation.
Will antibiotics prevent compli-
cations?
A systematic review5 of 12 RCTs
in children found no significant
difference in the rate of develop-
ment of otitis media or the pro-
gression of respiratory symptoms
(RR 0.71, 95% CI 0.45 - 1.12).
Do antibiotics cause harm?
In the systematic reviews men-
tioned above, adverse effects  of
antibiotics, such as gastrointestinal
disturbances, were 3 or 4 times
more common in adults when
treated with antibiotics, but not in
children.
The current evidence therefore
indicates that the main impact of
antibiotics for the common cold is
to produce adverse effects. The sys-
tematic reviews do not examine the
impact of antibiotic use on the
development of bacterial resis-
tance, which is an additional very
important reason not to prescribe
antibiotics.
CASE 2 
An 8-year-old girl from an outlying
area comes to town with her moth-
er on a once-a-day bus to see the
nearest general practitioner. She
has a fever and follicles on swollen,
red tonsils. The general practitioner
diagnoses tonsillitis, possibly due
to GABS.
What are the questions?
Here the questions are similar to
those in case 1, but the answers
may be very different.The tonsilli-
tis may be due to GABS and seems
more likely to benefit from an
antibiotic, and the potential com-
plications of the condition, such as
rheumatic fever and glomeru-
lonephritis, are more severe.
Will antibiotics reduce the
severity and duration of her
symptoms?
A systematic review of 25 RCTs of
antibiotics for sore throat found
that antibiotics had their greatest
effect at 3.5 days, by which time
50% of untreated patients had
recovered (OR 0.41, 95% CI 0.36
- 0.48).7 In other words, antibiotics
shorten the duration of illness by
an average of about 16 hours, and
one would need to treat approxi-
mately 5 people for 1 additional
person to have benefited at 3 days.
In deciding whether an antibiotic is
worth while for reducing symp-
toms, one must decide whether
these modest benefits are worth
the cost, adverse effects and pro-
motion of bacterial resistance,
remembering that analgesics are
also effective for reducing symp-
toms.8
Will antibiotics prevent compli-
cations?
In addition to relieving symptoms
there are of course other reasons
for treating this child with a sore
throat.The main one is to prevent
rheumatic fever. A systematic
review has found that antibiotics
reduce the development of
rheumatic fever by about two-
thirds (OR 0.30, 95% CI 0.20 -
0.45).7 So, how many people does
one need to treat to prevent 1 case
of rheumatic fever? This number
will vary greatly, depending on the
setting. It has been estimated that
it would have taken 12 GP life-
times to encounter 1 new case of
rheumatic fever in Western
Scotland in the 1980s.9
Unfortunately, in developing coun-
tries there is little evidence regard-
ing the risk of rheumatic fever
from a specific episode of sore
throat in a specific setting , and this
will vary greatly with age and
socio-economic setting. Poor socio-
economic circumstances greatly
increase the risk.Therefore, in the
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absence of adequate information, it
seems prudent to treat children
from poor socio-economic circum-
stances who are at the age of great-
est risk of streptococcal infection
and acute rheumatic fever (5 - 15
years). It does not make sense to
treat children under 3 years
because rheumatic fever is very
rare at this age. Incidentally, the
argument that the introduction of
antibiotics led to the reduction of
rheumatic fever is not very con-
vincing. In Denmark the incidence
of rheumatic fever was steadily
declining from 1900, and was




Would it be helpful to perform a
throat swab culture in this patient,
and delay treatment until the result
is available? This is the standard
approach in the USA. Apart from
the cost and organisational difficul-
ties (prohibitive in many situations)
the throat swab is not a good test.
There is a high carrier rate of
group A b-haemolytic streptococci
in people without symptoms, and
cultures from the surface of the
tonsil agree poorly with those from
deep in the tonsillar crypts.10
From published data (using the
antistreptolysin o titre (ASOT) as
the ‘gold standard’), the sensitivity
and specificity of throat swab cul-
ture are 26 - 30% and 73 - 80%,
respectively.11 In other words, in a
group of patients of whom 30%
have a streptococcal infection, we
would miss approximately 70% of
all these infections, and the posi-
tive predictive value of a positive
throat swab would be 40%, i.e.
more than 60% of those treated
with an antibiotic would not have
had a streptococcal infection.
Despite the widespread use of
throat swabs, when feasible, there
seems little reason to recommend
them.
Several studies have examined the
accuracy of clinical examination in
detecting streptococcal infections.
Generally, the accuracy has been
low, but these findings are difficult
to assess because most research has
used the throat swab as the ‘gold
standard’.
This case of tonsillitis illustrates a
common and important element of
an evidence-based approach. Good
evidence is not always available.
The size of the benefit of antibi-
otics in preventing rheumatic fever
is uncertain, and a particular
patient’s risk of developing
rheumatic fever after a particular
infection is at best an educated
guess. We have to find and use the
best available evidence, taking its
limitations into account.This
requires judgement. Different peo-
ple (both doctors and patients)
with different perspectives, person-
alities and values will arrive at dif-
ferent decisions in some specific
cases. This is not necessarily bad.
People’s needs and values differ.
An evidence-based approach
enables the best use of the limited
available evidence, and makes
more explicit the values underlying
the decision.This can help to
ensure that the patient’s values,
and not the doctor’s, are influenc-
ing the decision. Put another way,
an evidence-based approach does
not replace clinical judgement. It is
merely a tool to improve that
judgement and the well-being of
the patient.
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It does not make




very rare at this age.
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IN A NUTSHELL
Sore throat and URTI are com-
mon presenting problems in gen-
eral practice, and antibiotics are
commonly used.
Antibiotic resistance is a major
cost of widespread antibiotic use.
The main impact of antibiotics for
people with the common cold is
financial cost and adverse clinical
effects.
In one-half of patients with sore
throat, symptoms have improved
by day 3 of the illness, with or
without the use of antibiotics.
For sore throat, antibiotics shorten
the average duration of symptoms
by hours only, and analgesics are
an effective alternative for pain.
A throat swab culture is a poor
test for active streptococcal infec-
tion.
There is little reliable evidence
regarding the accuracy of clinical
signs for diagnosing ‘strep throat’.
Antibiotic treatment for sore
throat reduces the risk of
rheumatic fever.
Antibiotic treatment to reduce the
risk of rheumatic fever is pointless
in people with a very low risk, e.g.
children under 3 years and per-
haps people in good socio-eco -
nomic circumstances.
